Henry Ji
Wapampando, Purezidenti ndi CEO
- Zaka 25+ akugwira ntchito mu biotechnology ndi sayansi ya moyo
- Dr. Ji anayambitsa Sorrento ndipo wakhala mtsogoleri kuyambira 2006, CEO ndi Purezidenti kuyambira 2012, ndi Chairman kuyambira 2017.
- Munthawi yake ku Sorrento, adapanga ndikuwongolera kukula kwa Sorrento kudzera pakugula ndi kuphatikiza kuphatikiza Bioserv, Scilex Pharmaceuticals, Concortis Biotherapeutics, Levena Biopharma, LACEL, TNK Therapeutics, Virttu Biologics, Ark Animal Health, ndi Sofurysa Systems Lymphatic.
- Anatumikira monga Chief Scientific Officer wa Sorrento kuyambira 2008 mpaka 2012 komanso ngati Mtsogoleri Wachigawo wapakati kuyambira 2011 mpaka 2012.
- Sorrento isanachitike, adakhala ndi maudindo akuluakulu ku CombiMatrix, Stratagene komanso adayambitsanso Stratagene Genomics, nthambi ya Stratagene, ndipo adakhala Purezidenti & CEO ndi Director wa Board.
- BS ndi Ph.D.
Tsekani X
Dorman kutsatira
Director
- Bambo Followwill, akhala akutumikira monga wotsogolera kuyambira September 2017
- Wakhala Senior Partner, Transfformal Health ku Frost & Sullivan, kampani yowunikira bizinesi yomwe ikukhudzidwa ndi kafukufuku wamsika ndi kusanthula, kuwunikira njira zakukula ndi maphunziro amakampani m'mafakitale angapo, kuyambira 2016.
- Isanafike nthawi imeneyo, adagwira ntchito zosiyanasiyana ku Frost & Sullivan, kuphatikizapo Partner pa Executive Committee yoyang'anira P & L ya bizinesi ku Ulaya, Israel ndi Africa, ndi Partner akuyang'anira bizinesi ya Healthcare ndi Life Sciences ku North America, kuyambira poyamba adalowa nawo. Frost & Sullivan kuti athandizire kupeza njira ya Consulting mu Januware 1988
- Bambo Followwill ali ndi zaka zoposa 30 za utsogoleri wa bungwe ndi upangiri wa kasamalidwe, atagwira ntchito pamapulojekiti mazanamazana m'madera onse akuluakulu komanso m'magawo angapo amakampani, polojekiti iliyonse imayang'ana pa kufunikira kwa kukula.
- BA
Tsekani X
Kim D. Janda
Director
- Dr. Janda wakhala akutumikira monga director kuyambira April 2012
- Dr. Janda wakhala Ely R. Callaway, Jr. Pulofesa Wapampando ku Dipatimenti ya Chemistry, Immunology ndi Microbial Science ku The Scripps Research Institute ("TSRI") kuyambira 1996 komanso monga Mtsogoleri wa Worm Institute of Research and Medicine ( "WIRM") ku TSRI kuyambira 2005. Komanso, Dr. Janda wakhala akugwira ntchito ngati Skaggs Scholar mkati mwa Skaggs Institute of Chemical Biology, komanso ku TSRI, kuyambira 1996.
- Wasindikiza zolembedwa zoyambira 425 m'manyuzipepala owunikiridwa ndi anzawo ndipo adayambitsa makampani opanga biotechnological CombiChem, Drug Abuse Sciences ndi AIPartia Dr. Janda ndi mkonzi wothandizira wa "Bioorganic & Medicinal Chemistry", "PLoS ONE" ndipo amatumikira, kapena watumikirapo. , m’mabwalo a akonzi a magazini ambiri kuphatikizapo J. Comb. Chem., Chima. Ndemanga, J. Med. Chem., The Botulinum Journal, Bioorg. ndi Med. Chemu. Lett., ndi Bioorg. ndi Med. Chemu
- Kwa zaka zopitirira 25, Dr. Janda wapereka ndalama zambiri zopindulitsa ndipo amawerengedwa kuti ndi m'modzi mwa asayansi oyambirira kuphatikiza njira za mankhwala ndi zamoyo kukhala pulogalamu yofufuza yogwirizana.
- Dr. Janda wakhala akugwira ntchito mu Scientific Advisory Boards of Materia ndi Singapore Ministry of Education
- BS ndi Ph.D.
Tsekani X
David Lemus
Director
- Bambo Lemus akhala ngati director of Company kuyambira Seputembala 2017
- Pakadali pano ndi CEO wa Ironshore Pharmaceuticals, Inc.
- Kuphatikiza apo, amagwira ntchito ngati membala wosakhala wamkulu wa Silence Therapeutics (NASDAQ: SLN) ndi BioHealth Innovation, Inc.
- M'mbuyomu ku Sigma Tau Pharmaceuticals, Inc. kuyambira 2011-2015, adakhala ngati CEO.
- Kuphatikiza apo, Bambo Lemus adakhala ngati CFO ndi Wachiwiri kwa Wachiwiri kwa MorphoSys AG kuyambira 1998-2011, kutengera kampani pa IPO yoyamba yaukadaulo yaku Germany.
- Asanagwire ntchito ku MorphoSys AG, adakhala ndi maudindo osiyanasiyana monga Hoffman La Roche, Electrolux AB, ndi Lindt & Spruengli AG (Group Treasurer)
- BS, MS, MBA, CPA
Tsekani X
Jaisim Shah
Director
- A Shah akhala akutumikira monga director kuyambira 2013
- Zaka 25+ zazaka zambiri pantchito yazamankhwala
- Bambo Shah pano ndi CEO komanso Purezidenti wa Scilex Holding ndi Scilex Pharmaceutical.
- Asanakhale Scilex, adakhala ngati CEO ndi Purezidenti wa Semnur Pharmaceuticals (yomwe idagulidwa ndi Scilex Pharmaceuticals) kuyambira pomwe idakhazikitsidwa mu 2013.
- Kuyambira 2011 mpaka 2012, adagwira ntchito ngati Chief Business Officer wa Elevation Pharmaceuticals komwe adayang'ana kwambiri zandalama, kuphatikiza ndi kupeza, komanso chitukuko cha bizinesi.
- Asanafike Elevation, Bambo Shah anali Purezidenti wa Zelos Therapeutics, komwe adayang'ana kwambiri zandalama ndi chitukuko cha bizinesi.
- Asanayambe Zelos, Bambo Shah anali Wachiwiri Wachiwiri ndi Chief Business Officer ku CytRx. M'mbuyomu, Bambo Shah anali Chief Business Officer ku Facet Biotech ndi PDL BioPharma komwe adamaliza kupereka zilolezo / mgwirizano ndi njira zoyendetsera ntchito.
- PDL isanachitike, Bambo Shah anali Wachiwiri kwa Wachiwiri kwa Global Marketing ku BMS komwe adalandira "Presidents Award" chifukwa chomaliza ntchito imodzi yofunika kwambiri m'mbiri ya kampaniyo.
- MA ndi MBA
Tsekani X
Ndi Alexander Wu
Director
- Dr. Wu wakhala akutumikira monga director kuyambira August 2016
- Pakadali pano amagwiranso ntchito ku BOD ya Scilex Pharmaceutical kuyambira 2019
- Dr. Wu anali woyambitsa nawo, CEO, Purezidenti, ndi Chief Scientific Officer wa Crown Bioscience International, kampani yotsogola padziko lonse lapansi yopezera mankhwala osokoneza bongo komanso njira zothetsera mavuto, yomwe adayambitsanso mu 2006.
- Kuyambira 2004 mpaka 2006, anali Chief Business Officer wa Starvax International Inc. ku Beijing, China, kampani ya biotechnology yomwe imayang'ana kwambiri za oncology ndi matenda opatsirana.
- Kuyambira 2001 mpaka 2004, anali banki ndi Burrill & Company komwe anali mtsogoleri wa Asian Activities.
- BS, MS, MBA, ndi Ph.D.
Tsekani X